These results demonstrate the importance of measuring levels of BMPR1A, ΔNp73 and even more so of NANOG, as they could contribute to predicting at diagnosis the risk of relapse of AML patients. The gene discussed is BMPR1A; the disease is acute myeloid leukemia.